Colon and Rectal Surgery Educational Program (CARSEP XI) is the latest self-assessment program provided by the American Society of Colon and Rectal Surgeons (ASCRS). CARSEP is designed to provide surgeons with in-depth and up-to-date knowledge relative to surgery of the colon and rectum.

Test your knowledge to prepare for the qualifying examination of the American Board of Colon and Rectal Surgery (ABCRS) or to earn continuing medical education (CME) applicable towards Continuous Certification Self-Assessment credit, and stay current with the latest practice recommendations.

CME Credit Hours: 75 AMA PRA Category 1 Credit(s)™ applicable towards Continuous Certification Self-Assessment credit.
Release Date: March 1, 2022
CME Expires: February 28, 2025

Learning Objectives

At the conclusion of this program, physicians should be able to:

• assess how to make decisions in common clinical situations; where he/she is likely to err and then develop his/her own self-assessment program of improvement.
• increase his/her knowledge of the latest findings in the field of colon and rectal surgery
• identify strengths and weaknesses in the practice of colon and rectal surgery

Target Audience

The program is intended for the education of colon and rectal surgeons as well as general surgeons and others involved in the treatment of diseases affecting the colon, rectum and anus.

Accreditation

The American Society of Colon and Rectal Surgeons (ASCRS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Getting started

Anorectal Disease

This pillar encompasses the broad spectrum of anorectal disease such as hemorrhoids, fissures, abscess/fistula, pilonidal disease, infectious disease and perianal dermatology. In addition to the evaluation and testing options available, both non-operative and surgical treatments are discussed.

Benign Disease

This pillar encompasses a broad range of benign colorectal conditions from diverticular disease and colorectal trauma to lower gastrointestinal bleeding and the various colitides. Included here is an in-depth discussion regarding the evaluation and treatment of patients with inflammatory bowel disease.

Malignancy

This pillar encompasses the evaluation, staging and management for more common colorectal tumors such as colorectal and anal cancer. In addition, less common malignancies such as carcinoid, melanoma and GISTs are reviewed. Other topics include the pathogenesis, epidemiology and screening/surveillance strategies for colorectal cancer. Management is broken down into neoadjuvant, adjuvant and surgical therapy, as well as approaches to locally advanced, recurrent and Stage IV disease. This section also presents a detailed discussion on colorectal polyps including hereditary neoplasms, polyposis and other genetic syndromes.

Pelvic Floor

This pillar encompasses the wide range of conditions that affect the pelvic floor and defecatory function. Constipation, fecal incontinence, and pelvic floor prolapse are covered in-depth, including evaluation strategies and operative and non-operative treatment regimens for each condition.

Perioperative (Includes Endoscopy)

This pillar encompasses the diagnostic evaluation, perioperative optimization, and risk stratification for patients undergoing colorectal surgery. Included in this section are detailed discussions on topics ranging from colorectal anatomy and physiology to radiographic studies and endoscopy. Additionally, various methods to assess and optimize patients preoperatively as well as identify and manage postoperative complications are discussed.

Miscellaneous

This pillar encompasses various topics that involve the operative, office, and non-clinical settings. Discussions regarding quality, economics and practice management, as well as minimally invasive approaches and care for the pediatric patient are included.

Self-Assessment Committee

Conflict of Interest Policy

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American Society of Colon and Rectal Surgeons (ASCRS) policy, all educational planners, presenters, instructors, authors, reviewers and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 24 months. All identified conflicts of interest have been resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that a disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of ASCRS.

Every person who is involved in the planning of this CME program has been asked to provide information regarding any financial relationships with commercial interest as defined by the ACCME. They have disclosed.

Committee members not listed here have indicated they have nothing to disclosure. All identified conflicts of interest have been resolved.

Copyright

CARSEP XI
© 2022 American Society of Colon and Rectal Surgeons. All rights reserved.

Unbound™ software platform
© 2000-2022 Unbound Medicine, Inc. All rights reserved.